Status:
COMPLETED
Developmental Outcomes
Lead Sponsor:
University of Florida
Collaborating Sponsors:
American Heart Association
Conditions:
Hypoxic-Ischemic Encephalopathy
Eligibility:
All Genders
18-20 years
Brief Summary
Determine whether the concentrations of UCH-L1 and GFAP measured in umbilical cord blood and in blood 0-6 hours postnatal accurately predict the extent of neurodevelopmental deficits and/or death at 1...
Detailed Description
Children born with Hypoxic Ischemic Encephalopathy (HIE) and already enrolled in IRB #504-2011 will be seen for a developmental follow-up at 18-20 months of age. The developmental assessment tool that...
Eligibility Criteria
Inclusion
- children already enrolled in IRB#504-2011
- 18-20 months of age
Exclusion
- none
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 3 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02264808
Start Date
November 1 2014
End Date
December 3 2018
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610